Magali Traskine
About
Magali Traskine is a scholar working on Epidemiology, Microbiology and Pediatrics, Perinatology and Child Health.
According to data from OpenAlex, Magali Traskine has authored 18 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 12 papers in Microbiology and 2 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Magali Traskine's work include Pneumonia and Respiratory Infections (18 papers), Respiratory viral infections research (13 papers) and Bacterial Infections and Vaccines (12 papers). Magali Traskine is often cited by papers focused on Pneumonia and Respiratory Infections (18 papers), Respiratory viral infections research (13 papers) and Bacterial Infections and Vaccines (12 papers). Magali Traskine collaborates with scholars based in Belgium, Czechia and Poland. Magali Traskine's co-authors include Dorota Borys, J. Rüggeberg, Lode Schuerman, Taneli Puumalainen, Marta Moreira, Roman Prymula, Patricia Lommel, Terhi Kilpi, Hanna Rinta‐Kokko and Arto A. Palmu and has published in prestigious journals such as The Lancet Infectious Diseases, Vaccine and The Pediatric Infectious Disease Journal.
In The Last Decade
Magali Traskine
18 papers receiving 434 citations
Peers
Magali Traskine
Judith Spijkerman Netherlands
Satu Rapola Finland
Rebecca Findlay New Zealand
Rodrigo Vergara Chile
Keith Cartwright United Kingdom
Reiko Takayanagi Japan
Maria Paula Bajanca-Lavado Portugal
M. Jordan Theodore United States
Paola Vacca Italy
Isabelle Henckaerts Belgium
Citations per year, relative to Magali Traskine Magali Traskine (= 1×)
peers
Judith Spijkerman
Countries citing papers authored by Magali Traskine
Since
Specialization
Citations
This map shows the geographic impact of Magali Traskine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magali Traskine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magali Traskine more than expected).
Fields of papers citing papers by Magali Traskine
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Magali Traskine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magali Traskine. The network helps show where Magali Traskine may publish in the future.
Co-authorship network of co-authors of Magali Traskine
This figure shows the co-authorship network connecting the top 25 collaborators of Magali Traskine. A scholar is included among the top collaborators of Magali Traskine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magali Traskine. Magali Traskine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Weber, M, Magali Traskine, Ana Strezova, et al.. (2020). Can two different pneumococcal conjugate vaccines be used to complete the infant vaccination series? A randomized trial exploring interchangeability of the 13-valent pneumococcal conjugate vaccine and the pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine. Expert Review of Vaccines. 19(11). 995–1010.
2.
Odutola, Aderonke, Martin O. C. Ota, Martín Antonio, et al.. (2019). Immunogenicity of pneumococcal conjugate vaccine formulations containing pneumococcal proteins, and immunogenicity and reactogenicity of co-administered routine vaccines – A phase II, randomised, observer-blind study in Gambian infants. Vaccine. 37(19). 2586–2599.
3.
Hammitt, Laura L., James C. Campbell, Dorota Borys, et al.. (2019). Efficacy, safety and immunogenicity of a pneumococcal protein-based vaccine co-administered with 13-valent pneumococcal conjugate vaccine against acute otitis media in young children: A phase IIb randomized study. Vaccine. 37(51). 7482–7492.
4.
Nolan, Terry, Robert Booy, Helen Marshall, et al.. (2019). Immunogenicity and Safety of a Quadrivalent Meningococcal ACWY-tetanus Toxoid Conjugate Vaccine 6 Years After MenC Priming as Toddlers. The Pediatric Infectious Disease Journal. 38(6). 643–650.
5.
Dbaibo, Ghassan, et al.. (2018). Immunogenicity and safety of MenACWY-TT, a meningococcal conjugate vaccine, co-administered with routine childhood vaccine in healthy infants: A phase III, randomized study. Vaccine. 36(28). 4102–4111.
6.
Prymula, Roman, Jerzy Brzostek, Leszek Szenborn, et al.. (2018). Immunogenicity and safety of 11- and 12-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccines (11vPHiD-CV, 12vPHiD-CV) in infants: Results from a phase II, randomised, multicentre study. Vaccine. 37(1). 176–186.
7.
Kilpi, Terhi, Janne J. Jokinen, Taneli Puumalainen, et al.. (2018). Effectiveness of pneumococcal Haemophilus influenzae protein D conjugate vaccine against pneumonia in children: A cluster-randomised trial. Vaccine. 36(39). 5891–5901.
8.
Zaman, Khalequ, Asma Binte Aziz, Magali Traskine, et al.. (2017). Immunologic non-inferiority and safety of the investigational pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (PHiD-CV) 4-dose vial presentation compared to the licensed PHiD-CV 1-dose vial presentation in infants: A phase III randomized study. Vaccine. 36(5). 698–706.
9.
Prymula, Roman, Leszek Szenborn, Sven‐Arne Silfverdal, et al.. (2017). Safety, reactogenicity and immunogenicity of two investigational pneumococcal protein-based vaccines: Results from a randomized phase II study in infants. Vaccine. 35(35). 4603–4611.
10.
Vesikari, Timo, Aino Forstén, Tarja Kaijalainen, et al.. (2016). Effectiveness of the 10-Valent Pneumococcal NontypeableHaemophilus influenzaeProtein D–Conjugated Vaccine (PHiD-CV) Against Carriage and Acute Otitis Media—A Double-Blind Randomized Clinical Trial in Finland. Journal of the Pediatric Infectious Diseases Society. 5(3). 237–248.
11.
Prymula, Roman, Leszek Szenborn, Sven‐Arne Silfverdal, et al.. (2016). Safety and Reactogenicity of the Booster Dose of 2 Investigational Protein-Based Pneumococcal Vaccine Formulations in Toddlers: A Phase II Randomized Trial. Open Forum Infectious Diseases. 3(suppl_1).
12.
Prymula, Roman, Leszek Szenborn, Sven‐Arne Silfverdal, et al.. (2016). Immunogenicity of the Booster Dose of 2 Investigational Protein-Based Pneumococcal Vaccine Formulations in Toddlers: A Phase II Randomized Trial. Open Forum Infectious Diseases. 3(suppl_1).
13.
Odutola, Aderonke, Martín Antonio, Patrick K. Owiafe, et al.. (2015). Reactogenicity, safety and immunogenicity of a protein-based pneumococcal vaccine in Gambian children aged 2–4 years: A phase II randomized study. Human Vaccines & Immunotherapeutics. 12(2). 393–402.
14.
Palmu, Arto A., Jukka Jokinen, Heta Nieminen, et al.. (2015). Effectiveness of the Ten-valent Pneumococcal Conjugate Vaccine Against Tympanostomy Tube Placements in a Cluster-randomized Trial. The Pediatric Infectious Disease Journal. 34(11). 1230–1235.
15.
Leroux‐Roels, Geert, Cathy Maes, Fien De Boever, et al.. (2014). Safety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults: A phase I/II randomized clinical study. Vaccine. 32(50). 6838–6846.
16.
Prymula, Roman, Petr Pazdiora, Magali Traskine, J. Rüggeberg, & Dorota Borys. (2014). Safety and immunogenicity of an investigational vaccine containing two common pneumococcal proteins in toddlers: A phase II randomized clinical trial. Vaccine. 32(25). 3025–3034.
17.
Palmu, Arto A., Jukka Jokinen, Heta Nieminen, et al.. (2013). Effect of pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) on outpatient antimicrobial purchases: a double-blind, cluster randomised phase 3–4 trial. The Lancet Infectious Diseases. 14(3). 205–212.
18.
Silfverdal, Sven‐Arne, et al.. (2011). Anamnestic Immune Response in 3- to 4-year-old Children Previously Immunized With 10-valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine as 2-dose or 3-dose Priming and a Booster Dose in the First Year of Life. The Pediatric Infectious Disease Journal. 30(9). e155–e163.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Judith Spijkerman Breakdown of academic impact, for papers by Satu Rapola Breakdown of academic impact, for papers by Rebecca Findlay Breakdown of academic impact, for papers by Rodrigo Vergara Breakdown of academic impact, for papers by Keith Cartwright Breakdown of academic impact, for papers by Reiko Takayanagi Breakdown of academic impact, for papers by Maria Paula Bajanca-Lavado Breakdown of academic impact, for papers by M. Jordan Theodore Breakdown of academic impact, for papers by Paola Vacca Breakdown of academic impact, for papers by Isabelle Henckaerts